A detailed history of Lauterbach Financial Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Lauterbach Financial Advisors, LLC holds 32,295 shares of PFE stock, worth $905,874. This represents 0.62% of its overall portfolio holdings.

Number of Shares
32,295
Previous 15,713 105.53%
Holding current value
$905,874
Previous $452,000 98.23%
% of portfolio
0.62%
Previous 0.33%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$25.89 - $29.73 $429,307 - $492,982
16,582 Added 105.53%
32,295 $896,000
Q4 2023

Jan 18, 2024

BUY
$26.13 - $33.94 $11,418 - $14,831
437 Added 2.86%
15,713 $452,000
Q1 2023

May 01, 2023

SELL
$39.39 - $51.28 $18,631 - $24,255
-473 Reduced 3.0%
15,276 $623,000
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $45,750 - $56,690
-1,000 Reduced 5.97%
15,749 $815,000
Q4 2021

Feb 08, 2022

BUY
$41.32 - $61.25 $692,068 - $1.03 Million
16,749 New
16,749 $989,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lauterbach Financial Advisors, LLC Portfolio

Follow Lauterbach Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lauterbach Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lauterbach Financial Advisors, LLC with notifications on news.